NASDAQ:SXTC - China SXT Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$6.13 -0.02 (-0.33 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$6.13
Today's Range$6.02 - $6.5490
52-Week Range$3.62 - $23.35
Volume359,118 shs
Average Volume186,182 shs
Market Capitalization$137.93 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives. China SXT Pharmaceuticals, Inc. was founded in 2005 and is based in Taizhou, China.

Receive SXTC News and Ratings via Email

Sign-up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SXTC
CUSIPN/A
CIKN/A
Phone86-523-8629-8290

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.01 million

Profitability

Miscellaneous

EmployeesN/A
Market Cap$137.93 million
Next Earnings DateN/A
OptionableNot Optionable

China SXT Pharmaceuticals (NASDAQ:SXTC) Frequently Asked Questions

What is China SXT Pharmaceuticals' stock symbol?

China SXT Pharmaceuticals trades on the NASDAQ under the ticker symbol "SXTC."

Has China SXT Pharmaceuticals been receiving favorable news coverage?

Headlines about SXTC stock have trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. China SXT Pharmaceuticals earned a coverage optimism score of -1.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future.

Who are some of China SXT Pharmaceuticals' key competitors?

What other stocks do shareholders of China SXT Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China SXT Pharmaceuticals investors own include Aphria (APHA), TG Therapeutics (TGTX), Golden Minerals (AUMN), Cronos Group (CRON), Blink Charging (BLNK), Cesca Therapeutics (KOOL), Aurora Cannabis (ACB), Iconix Brand Group (ICON), NIO (NIO) and KITOV PHARMA LT/S (KTOV).

Who are China SXT Pharmaceuticals' key executives?

China SXT Pharmaceuticals' management team includes the folowing people:
  • Mr. Feng Zhou, Chairman & CEO (Age 27)
  • Mr. Yao Shi, Chief Financial Officer (Age 38)
  • Dr. Jingzhen Deng, Chief Scientific Officer & COO (Age 59)
  • Mr. Jun Zheng, Exec. Director (Age 40)

When did the company's quiet period expire?

China SXT Pharmaceuticals' quiet period expired on Wednesday, February 13th. China SXT Pharmaceuticals had issued 2,546,275 shares in its IPO on January 4th. The total size of the offering was $10,185,100 based on an initial share price of $4.00. During the company's quiet period, insiders and any underwriters that worked on the IPO were prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of China SXT Pharmaceuticals?

Shares of SXTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is China SXT Pharmaceuticals' stock price today?

One share of SXTC stock can currently be purchased for approximately $6.13.

How big of a company is China SXT Pharmaceuticals?

China SXT Pharmaceuticals has a market capitalization of $137.93 million and generates $7.01 million in revenue each year.

What is China SXT Pharmaceuticals' official website?

The official website for China SXT Pharmaceuticals is http://www.sxtchina.com.

How can I contact China SXT Pharmaceuticals?

China SXT Pharmaceuticals' mailing address is 178 TAIDONG ROAD NORTH, TAIZHOU F4, 225300. The company can be reached via phone at 86-523-8629-8290 or via email at [email protected]


MarketBeat Community Rating for China SXT Pharmaceuticals (NASDAQ SXTC)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  18 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  56
MarketBeat's community ratings are surveys of what our community members think about China SXT Pharmaceuticals and other stocks. Vote "Outperform" if you believe SXTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SXTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel